Barriere G, Pelloquin-Mvogo Z, Boulain M, Khsime I, Bharatiya R, Riquier M
Int J Mol Sci. 2025; 26(5).
PMID: 40076918
PMC: 11901079.
DOI: 10.3390/ijms26052298.
Melo-Thomas L, Tacken L, Richter N, Almeida D, Raposo C, de Melo S
eNeuro. 2022; .
PMID: 35817565
PMC: 9337613.
DOI: 10.1523/ENEURO.0076-22.2022.
Turk A, Lotfi Marchoubeh M, Fritsch I, Maguire G, SheikhBahaei S
Brain Lang. 2021; 219:104970.
PMID: 34098250
PMC: 8260450.
DOI: 10.1016/j.bandl.2021.104970.
Coyle J, Schwarcz R
Front Neurosci. 2020; 14:927.
PMID: 33013307
PMC: 7509407.
DOI: 10.3389/fnins.2020.00927.
Schwerdt H, Zhang E, Kim M, Yoshida T, Stanwicks L, Amemori S
Commun Biol. 2018; 1:144.
PMID: 30272020
PMC: 6135761.
DOI: 10.1038/s42003-018-0147-y.
Beneficial effects of for the treatment and prevention of neurodegenerative diseases: past findings and future directions.
Kim K, Lee D, Lee H, Kim C, Jung K, Kang K
J Ginseng Res. 2018; 42(3):239-247.
PMID: 29989012
PMC: 6035378.
DOI: 10.1016/j.jgr.2017.03.011.
Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
Arora D, Mudgal J, Nampoothiri M, Mallik S, Kinra M, Hall S
Metab Brain Dis. 2018; 33(4):1045-1051.
PMID: 29516413
DOI: 10.1007/s11011-018-0201-y.
Subthalamic and Cortical Local Field Potentials Associated with Pilocarpine-Induced Oral Tremor in the Rat.
Long L, Podurgiel S, Haque A, Errante E, Chrobak J, Salamone J
Front Behav Neurosci. 2016; 10:123.
PMID: 27378874
PMC: 4911403.
DOI: 10.3389/fnbeh.2016.00123.
Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
Burke M, Nocjar C, Sonneborn A, McCreary A, Pehek E
J Neurochem. 2014; 131(4):432-43.
PMID: 25073477
PMC: 5329890.
DOI: 10.1111/jnc.12842.
Effects of dopaminergic therapy on locomotor adaptation and adaptive learning in persons with Parkinson's disease.
Roemmich R, Hack N, Akbar U, Hass C
Behav Brain Res. 2014; 268:31-9.
PMID: 24698798
PMC: 4034129.
DOI: 10.1016/j.bbr.2014.03.041.
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications.
Fiandaca M, Bankiewicz K, Federoff H
Pharmaceuticals (Basel). 2013; 5(6):553-90.
PMID: 24281662
PMC: 3763661.
DOI: 10.3390/ph5060553.
Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions.
Herrera-Marschitz M, Meana J, OConnor W, Goiny M, Reid M, Ungerstedt U
Amino Acids. 2013; 2(1-2):157-79.
PMID: 24194283
DOI: 10.1007/BF00806086.
Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.
Navailles S, Lagiere M, Contini A, De Deurwaerdere P
ACS Chem Neurosci. 2013; 4(5):680-92.
PMID: 23541043
PMC: 3656765.
DOI: 10.1021/cn400046e.
Renal failure in dementia with lewy bodies presenting as catatonia.
Fekete R
Case Rep Neurol. 2013; 5(1):10-3.
PMID: 23466522
PMC: 3573819.
DOI: 10.1159/000346594.
Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease.
Wang M, Lu C, Roisen F
Stem Cells Transl Med. 2012; 1(6):492-502.
PMID: 23197853
PMC: 3659713.
DOI: 10.5966/sctm.2012-0012.
The absorption and metabolism of a standard oral dose of levodopa in patients with Parkinsonism.
Bergmann S, Curzon G, Friedel J, Godwin-Austen R, Marsden C, Parkes J
Br J Clin Pharmacol. 2012; 1(5):417-24.
PMID: 22454921
PMC: 1402477.
DOI: 10.1111/j.1365-2125.1974.tb00280.x.
Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.
Navailles S, De Deurwaerdere P
Parkinsons Dis. 2011; 2012:323686.
PMID: 22007343
PMC: 3191743.
DOI: 10.1155/2012/323686.
Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.
Collins-Praino L, Paul N, Rychalsky K, Hinman J, Chrobak J, Senatus P
Front Syst Neurosci. 2011; 5:49.
PMID: 21772815
PMC: 3131529.
DOI: 10.3389/fnsys.2011.00049.
Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.
Kumar A, Ownby R, Waldrop-Valverde D, Fernandez B, Kumar M
J Neurovirol. 2010; 17(1):26-40.
PMID: 21165787
DOI: 10.1007/s13365-010-0003-4.
Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism.
Salamone J, Ishiwari K, Betz A, Farrar A, Mingote S, Font L
Parkinsonism Relat Disord. 2008; 14 Suppl 2:S130-4.
PMID: 18585081
PMC: 2806674.
DOI: 10.1016/j.parkreldis.2008.04.017.
